ATE148122T1 - Optisch aktive thienotriazolodiazepin- verbindungen - Google Patents

Optisch aktive thienotriazolodiazepin- verbindungen

Info

Publication number
ATE148122T1
ATE148122T1 AT91117375T AT91117375T ATE148122T1 AT E148122 T1 ATE148122 T1 AT E148122T1 AT 91117375 T AT91117375 T AT 91117375T AT 91117375 T AT91117375 T AT 91117375T AT E148122 T1 ATE148122 T1 AT E148122T1
Authority
AT
Austria
Prior art keywords
carbon atoms
alkyl
optically active
hydrogen
active thienotriazolodiazepine
Prior art date
Application number
AT91117375T
Other languages
English (en)
Inventor
Minoru Moriwaki
Syuji Yuasa
Hiroyuki Kitani
Michio Terasawa
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Application granted granted Critical
Publication of ATE148122T1 publication Critical patent/ATE148122T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT91117375T 1990-10-12 1991-10-11 Optisch aktive thienotriazolodiazepin- verbindungen ATE148122T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27445190 1990-10-12
JP21451291 1991-07-31

Publications (1)

Publication Number Publication Date
ATE148122T1 true ATE148122T1 (de) 1997-02-15

Family

ID=26520357

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91117375T ATE148122T1 (de) 1990-10-12 1991-10-11 Optisch aktive thienotriazolodiazepin- verbindungen

Country Status (9)

Country Link
US (1) US5286858A (de)
EP (1) EP0480455B1 (de)
JP (1) JP2959598B2 (de)
KR (1) KR940006633B1 (de)
AT (1) ATE148122T1 (de)
CA (1) CA2053123A1 (de)
DE (1) DE69124330T2 (de)
DK (1) DK0480455T3 (de)
ES (1) ES2099114T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3239364B2 (ja) * 1991-10-11 2001-12-17 ウェルファイド株式会社 骨粗鬆症治療薬およびジアゼピン化合物
CN1984887B (zh) * 2004-07-13 2010-07-28 大鹏药品工业株式会社 甲磺司特结晶的均匀性评价方法、均匀的结晶及其制造方法
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
WO2012151512A2 (en) 2011-05-04 2012-11-08 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2012174487A2 (en) 2011-06-17 2012-12-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2013184878A1 (en) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
CN106687463B (zh) 2014-06-20 2019-04-09 星座制药公司 一种乙酰胺类化合物的晶型
CR20230211A (es) 2020-11-16 2023-07-13 Boehringer Ingelheim Int Derivados de ciclopentatiofen carboxamida como antagonistas del receptor del factor de activación de plaquetas
JP2025501761A (ja) 2021-12-22 2025-01-23 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 血小板活性化因子受容体アンタゴニストとしてのシクロペンタチオフェンカルボキサミド誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2039408T3 (es) * 1986-11-17 1993-10-01 Yoshitomi Pharmaceutical Industries, Ltd. Un procedimiento para preparar un compuesto de tienotriazolodiazepina.
DE3878833T2 (de) * 1987-05-28 1993-06-09 Yoshitomi Pharmaceutical Thieno(triazolo)diazepinverbindungen, und medizinische verwendung derselben.
MC1999A1 (fr) * 1987-12-18 1990-01-26 Hoffmann La Roche Composes tricycliques
CA1324863C (en) * 1988-01-30 1993-11-30 Welfide Corporation Thienotriazolodiazepine compounds and pharmaceutical uses thereof
DE4010528A1 (de) * 1990-04-02 1991-10-17 Boehringer Ingelheim Kg Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine

Also Published As

Publication number Publication date
CA2053123A1 (en) 1992-04-13
ES2099114T3 (es) 1997-05-16
DK0480455T3 (da) 1997-02-10
DE69124330T2 (de) 1997-07-03
JP2959598B2 (ja) 1999-10-06
EP0480455B1 (de) 1997-01-22
DE69124330D1 (de) 1997-03-06
KR920008048A (ko) 1992-05-27
US5286858A (en) 1994-02-15
KR940006633B1 (ko) 1994-07-23
EP0480455A1 (de) 1992-04-15
JPH0586067A (ja) 1993-04-06

Similar Documents

Publication Publication Date Title
NL300396I1 (nl) Nieuwe derivaten met naftalinestructuren, werkwijze voor de bereiding ervan en de farmaceutische preparaten die deze bevatten
ES8105705A1 (es) Un procedimiento para la preparacion de sulfonamidas.
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
AU636351B2 (en) N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments
DE69124330D1 (de) Optisch aktive Thienotriazolodiazepin-Verbindungen
HUT68721A (en) Benzofuran and benzizoxazole derivatives, pharmaceutical composition containing said compounds as active agent and process for preparing them
ES8706144A1 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
PT91607A (pt) Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them
ATE125809T1 (de) Kristallform des 4-(5,6,7,8-tetrahydroimidazo(1,5-a>pyridin-5-yl -benzonitril-hydrochlorids.
ATE48994T1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
DE3069173D1 (en) Substituted phenylamino-2-imidazoline-2 derivatives, their acid addition salts, medicaments containing them and process for their preparation
ATE70842T1 (de) Bakterizide pyridobenzothiazinderivate mit langer wirkungsdauer.
ATE22081T1 (de) Substituierte thienobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE79618T1 (de) Thiadiazolguanidine.
SE8400451D0 (sv) Bronchodilatory azepino /1,2-a/pyrimidine derivatives and acid addition salts thereof and pharmaceutical compositions containig same
DE69419083D1 (de) Salmycine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
TH14552B (th) วิธียับยั้งการเจริญเติบโตของเส้นโลหิตโรคเกี่ยวกับการเจริญเติบโตของเส้นโลหิต
TH18912A (th) วิธียับยั้งการเจริญเติบโตของเส้นโลหิตโรคเกี่ยวกับการเจริญเติบโตของเส้นโลหิต
TH37483A (th) อนุพันธ์ 5-เมโรอิลแนพธาลีน
TH4616B (th) อนุพันธ์ของควิโนลีน-3-คาร์บอกซิลิค แอซิตการ?เตรียมและการใช้สารเหล่านี้
MY104164A (en) Heterocyclic compounds.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
REN Ceased due to non-payment of the annual fee